The benign prostatic hyperplasia (BPH) prostate treatment market is anticipated to be worth USD 33,031.10 million in 2024. The market is expected to grow at a steady rate over the period from 2024 to 2034, with a CAGR of 3.6%. By the end of the forecast period, the market value is predicted to hit USD 47,045.80 million.
Attributes | Details |
---|---|
Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Value for 2024 | USD 33,031.10 million |
Projected Market Value for 2034 | USD 47,045.80 million |
Value-based CAGR of Market for 2024 to 2034 | 3.6% |
Drugs continue to be the preferred treatment type for BPH. Institutional sales top the distribution channel segment.
For 2024, drugs are expected to account for 65.2% of the market share by treatment type. Some of the key drivers for the increasing use of drugs in BPH treatment are:
Attributes | Details |
---|---|
Top Treatment Type | Drugs |
Market Share (2024) | 65.2% |
Institutional sales are anticipated to account for 64.7% of the market share in 2024. Some of the key drivers for the progress of institutional sales include:
Attributes | Details |
---|---|
Top Distribution Channel | Institutional Sales |
Market Share (2024) | 64.7% |
The increasing geriatric population is contributing to the market’s acceleration in North America. The presence of a wide variety of treatments is also propelling the benign prostatic hyperplasia (BPH) prostate treatment industry in North America.
Advancement of research institutions is lending a helping hand to the progress of the market in the region. The focus on the technological development of healthcare companies in the region is making sure BPH treatment keeps up with the times in Europe.
Countries | CAGR |
---|---|
United States | 4.0% |
Canada | 3.1% |
United Kingdom | 3.7% |
France | 3.3% |
Italy | 3.5% |
The market is set to register a CAGR of 4.0% in the United States for the forecast period. The key drivers for growth are:
The CAGR for the benign prostatic hyperplasia (BPH) prostate treatment market in Canada is tipped to be 3.1% over the forecast period. Some of the key factors driving the growth are:
The CAGR for the benign prostatic hyperplasia (BPH) prostate treatment market in the United Kingdom is tipped to be 3.7% over the forecast period. Some of the key factors driving the growth are:
The market is expected to register a CAGR of 3.3% in France for the forecast period. Some of the key trends include:
The market is expected to register a CAGR of 3.5% in Italy over the forecast period. Some of the key trends include:
The benign prostatic hyperplasia (BPH) prostate treatment market is competitive, though a few companies are prominent in the market. One of the well-established companies in the market is Pfizer Inc., who are concentrated on expansion through its alpha-blockers range.
Other players in the market are implementing strategies such as acquisitions and mergers to get a competitive edge. Research and development are also given importance by these market players.
Recent Developments in the Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market
Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Size and Share Analysis Global BPH Treatment Device Market Forecast BPH therapy market coverage Prostate enlargement treatment market assessment BPH medication market report Emerging trends in surgical BPH treatment analysis
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 11: Western Europe Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 12: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 15: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: East Asia Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 21: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 7: Global Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 8: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 9: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 10: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 13: Global Market Attractiveness by Treatment Type, 2024 to 2034
Figure 14: Global Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 15: Global Market Attractiveness by Region, 2024 to 2034
Figure 16: North America Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 17: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 22: North America Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 23: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 24: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 28: North America Market Attractiveness by Treatment Type, 2024 to 2034
Figure 29: North America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 30: North America Market Attractiveness by Country, 2024 to 2034
Figure 31: Latin America Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 32: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 40: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 43: Latin America Market Attractiveness by Treatment Type, 2024 to 2034
Figure 44: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 46: Western Europe Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 47: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 52: Western Europe Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 55: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 58: Western Europe Market Attractiveness by Treatment Type, 2024 to 2034
Figure 59: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 61: Eastern Europe Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 62: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 73: Eastern Europe Market Attractiveness by Treatment Type, 2024 to 2034
Figure 74: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 76: South Asia and Pacific Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 77: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 88: South Asia and Pacific Market Attractiveness by Treatment Type, 2024 to 2034
Figure 89: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 91: East Asia Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 92: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 97: East Asia Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 100: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 101: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 103: East Asia Market Attractiveness by Treatment Type, 2024 to 2034
Figure 104: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 106: Middle East and Africa Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 107: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 118: Middle East and Africa Market Attractiveness by Treatment Type, 2024 to 2034
Figure 119: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The benign prostatic hyperplasia (BPH) prostate treatment market size is expected to be worth USD 33,031.10 million in 2024.
The benign prostatic hyperplasia (BPH) prostate treatment market is estimated to get as big as USD 47,045.80 million in 2034.
The CAGR of the benign prostatic hyperplasia (BPH) prostate treatment market during the 2024 to 2034 period in the United States is estimated to be 4.0%.
The benign prostatic hyperplasia (BPH) prostate treatment market can be divided into the following segments: treatment type and distribution channel.
The benign prostatic hyperplasia (BPH) prostate treatment market is expected to grow at a CAGR of 3.6% over the period from 2024 to 2034.
Pfizer Inc., NxThera Inc., NeoTract Inc., and Sanofi S.A. are some of the key companies in the benign prostatic hyperplasia (BPH) prostate treatment Market.
Explore Therapy Area Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.